Pyxis Oncology Inc Dividends
The next dividend date for Pyxis Oncology Inc has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Pyxis Oncology Inc (PYXS)
More About Pyxis Oncology Inc
Pyxis Oncology, Inc., a clinical stage company, engages in the development of therapeutics to treat solid tumors. Its lead antibody-drug conjugates (ADC) product candidate is PYX-201, an investigational novel ADC consisting of human immunoglobulin G1 (IgG1), which is in Phase 1 clinical trial to treat patients with relapsed or refractory solid tumors; and lead immuno-oncology (IO) product candidate is PYX-106, an investigational fully human IgG1 Siglec-15-targeting antibody that is in Phase 1 clinical trial to treat patients with advanced solid tumors. The company is also developing PYX-107, a CD40 agonist with demonstrated anti-cancer activity in patients with several cancer indications, which is in Phase 2 clinical trial for the treatment of tumors, such as soft tissue sarcomas, esophageal and gastroesophageal junction, cancers, and pancreatic ductal adenocarcinoma. It has in-license agreement with Pfizer Inc. to develop and commercialize ADC product candidates, including micvotabart pelidotin and PYX-203, and other ADC product candidates directed to the licensed targets; and Biosion USA, Inc. for development, manufacture, and commercialization of PYX-106, an IO product candidate. Pyxis Oncology, Inc. was incorporated in 2018 and is headquartered in Boston, Massachusetts.
Owning Pyxis Oncology Inc Stock on the Dividend Date
If you own Pyxis Oncology Inc stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Pyxis Oncology Inc stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Pyxis Oncology Inc stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Pyxis Oncology Inc stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Pyxis Oncology Inc dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More Pyxis Oncology Inc Dividends
You can contact us any time if you would like to ask questions about Pyxis Oncology Inc dividends or anything else related to the stock market.